Sinopharm applies for vaccine market approval
chinadaily.com.cn |
Updated: 2020-11-25 14:29
Share
Share - WeChat
Leading COVID-19 vaccine developer Sinopharm has submitted a market approval application to the top market regulator, according to media reports.
- Xinjiang to use geographical advantage to expand opening-up
- AI set to transform high-speed rail, adviser says
- Shanxi strengthens Yellow River basin governance
- Shenzhen park adjusts lighting for migratory birds
- Chinese airlines resume Middle East flights amid regional tensions
- Draft law will provide direction for further promotion of ethnic unity
